Evidence map›Paper›PMID 20385820›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression.

Kara Lukin, Scott Fields, Desiree Lopez, Marie Cherrier, Kristina Ternyak, Julita Ramírez, Ann J Feeney, James Hagman

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Loss ofOpen biology · 2018
    Article
  7. Molecular Regulation of Differentiation in Early B-Lymphocyte Development.International journal of molecular sciences · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome.American journal of human genetics · 2017
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kara LukinIntegrated Department of Immunology, National Jewish Health, Denver, CO 80206, USA.
Scott Fields
Desiree Lopez
Marie Cherrier
Kristina Ternyak
Julita Ramírez
Ann J Feeney
James Hagman
University of Colorado Denver · USNational Jewish Health · USScripps Research Institute · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
JUNCTIONAL DIVERSITY IN B AND T CELLSR01AI029672 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI FEENEY, ANN J · 1991 to 2009
$3.4M
Function and Regulation of Early B Cell Factor (EBF)R01AI054661 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R. · 2004 to 2011
$2.9M
Role of CTCF and Cohesin in V(D)J RearrangementR01AI082918 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI FEENEY, ANN J · 2010 to 2014
$2.4M
Regulation of B Cell Identity and Lineage ProgressionR01AI081878 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R. · 2010 to 2014
$1.9M
NIAID NIH HHS 5 T32 AI07405NIAID NIH HHS P01 AI022295NIAID NIH HHS P01 AI22295NIAID NIH HHS R01 AI029672NIAID NIH HHS R01 AI054661NIAID NIH HHS R01 AI081878NIAID NIH HHS R01 AI082918NIAID NIH HHS R01 AI29672NIAID NIH HHS R01AI54661NIAID NIH HHS T32 AI007405
6 · The paper itself

Abstract

Early B cell factor (EBF)1 is essential for B lineage specification. Previously, we demonstrated the synergistic activation of Cd79a (mb-1) genes by EBF1 and its functional partner, RUNX1. Here, we identified consequences of Ebf1 haploinsufficiency together with haploinsufficiency of Runx1 genes in mice. Although numbers of "committed" pro-B cells were maintained in Ebf1(+/-)Runx1(+/-) (ER(het)) mice, activation of B cell-specific gene transcription was depressed in these cells. Expression of genes encoding Aiolos, kappa0 sterile transcripts, CD2 and CD25 were reduced and delayed in ER(het) pro-B cells, whereas surface expression of BP-1 was increased on late pro-B cells in ER(het) mice. Late pre-B and immature and mature B cells were decreased in the bone marrow of Ebf1(+/-) (E(het)) mice and were nearly absent in ER(het) mice. Although we did not observe significant effects of haploinsuficiencies on IgH or Igkappa rearrangements, a relative lack of Iglambda rearrangements was detected in E(het) and ER(het) pre-B cells. Together, these observations suggest that B cell lineage progression is impaired at multiple stages in the bone marrow of E(het) and ER(het) mice. Furthermore, enforced expression of EBF1 and RUNX1 in terminally differentiated plasmacytoma cells activated multiple early B cell-specific genes synergistically. Collectively, these studies illuminate the effects of reduced Ebf1 dosage and the compounding effects of reduced Runx1 dosage. Our data confirm and extend the importance of EBF1 in regulating target genes and Ig gene rearrangements necessary for B cell lineage specification, developmental progression, and homeostasis.

Indexed as

AnimalsB-LymphocytesCD2 AntigensCell DifferentiationCell LineageCore Binding Factor Alpha 2 SubunitDNA PrimersFlow CytometryGene DosageGene Expression Regulation, DevelopmentalIkaros Transcription FactorInterleukin-2 Receptor alpha SubunitMiceReverse Transcriptase Polymerase Chain ReactionTrans-ActivatorsCD2 AntigensCore Binding Factor Alpha 2 SubunitDNA PrimersEbf1 protein, mouseIkaros Transcription FactorIkzf3 protein, mouseInterleukin-2 Receptor alpha SubunitRunx1 protein, mouseTrans-Activators

Identifiers

PMID20385820
PMCPMC2867885
OpenAlexW2025153452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.